These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26333502)

  • 1. [Intervention efficacy of lamivudine on liver dysfunction in patients undergoing anti-tuberculosis treatment for pulmonary tuberculosis complicated with 
chronic hepatitis B: a Meta-analysis].
    Hui S; Chen L; Li Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):912-20. PubMed ID: 26333502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review.
    Liang J; Tang YF; Wu FS; Deng X
    Pharmazie; 2012 Nov; 67(11):883-90. PubMed ID: 23210236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B.
    Zhang L; Hao CQ; Liu JF; Wang M
    Virol J; 2013 Apr; 10():134. PubMed ID: 23627972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.
    Yuan Y; Iloeje UH; Hay J; Saab S
    J Manag Care Pharm; 2008; 14(1):21-33. PubMed ID: 18240879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Sun LJ; Yu JW; Zhao YH; Kang P; Li SC
    J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.
    Yu S; Luo H; Pan M; Luis AP; Xiong Z; Shuai P; Zhang Z
    Int J Clin Pharm; 2016 Oct; 38(5):1035-43. PubMed ID: 27450506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
    Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
    Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum alanine aminotransferase levels in telbivudine versus lamivudine treatment for chronic hepatitis B: a meta-analysis.
    Dai M; Xiao GM; Wang FL; Zhang JS; Li YM; Yang HZ
    J Int Med Res; 2015 Apr; 43(2):161-72. PubMed ID: 25687498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of Lamivudine plus adefovir versus entecavir in the treatment of Lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.
    Huang ZB; Zhao SS; Huang Y; Dai XH; Zhou RR; Yi PP; Chen RC; Li WT; Zhang BX; Li N; Fan XG
    Clin Ther; 2013 Dec; 35(12):1997-2006. PubMed ID: 24238791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine].
    Bai SL; Hu XY; Zhong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1243-7. PubMed ID: 19173973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllanthus species for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008960. PubMed ID: 21491412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.
    Yang DH; Xie YJ; Zhao NF; Pan HY; Li MW; Huang HJ
    World J Gastroenterol; 2015 Mar; 21(9):2746-53. PubMed ID: 25759545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management.
    Liu Z; Jiang L; Liang G; Song E; Jiang W; Zheng Y; Gong C
    J Viral Hepat; 2017 Jul; 24(7):561-572. PubMed ID: 28072494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome].
    Tang CL; Zhou Z; Shi WQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):20-4. PubMed ID: 22500384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.
    Zhong JH; Li le Q; Wu LC
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008713. PubMed ID: 22161435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of xiaozhang recipe combined with lamivudine in treatment of 84 chronic viral hepatitis B patients with compensated liver cirrhosis].
    Zhou ZH; Li M; Huang LY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1220-3. PubMed ID: 22013800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.
    Peng H; Liu J; Yang M; Tong S; Yin W; Tang H; Hu P; Hu H; Ren H
    J Clin Pharmacol; 2014 Feb; 54(2):189-200. PubMed ID: 24105676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.